Oncology Institute Inc (TOI)vsUniversal Health Services Inc (UHS)
TOI
Oncology Institute Inc
$3.13
-2.49%
HEALTHCARE · Cap: $288.00M
UHS
Universal Health Services Inc
$186.72
+0.43%
HEALTHCARE · Cap: $11.41B
Smart Verdict
WallStSmart Research — data-driven comparison
Universal Health Services Inc generates 3992% more annual revenue ($17.36B vs $424.38M). UHS leads profitability with a 8.6% profit margin vs -15.5%. UHS earns a higher WallStSmart Score of 76/100 (B+).
TOI
Hold42
out of 100
Grade: D
UHS
Strong Buy76
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for TOI.
Margin of Safety
+78.6%
Fair Value
$1081.08
Current Price
$186.72
$894.36 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Revenue surging 21.5% year-over-year
Attractively priced relative to earnings
Every $100 of equity generates 21 in profit
Reasonable price relative to book value
Earnings expanding 42.7% YoY
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -6.5% — below average capital efficiency
No major concerns identified
Comparative Analysis Report
WallStSmart ResearchBull Case : TOI
The strongest argument for TOI centers on Debt/Equity, Revenue Growth. Revenue growth of 21.5% demonstrates continued momentum.
Bull Case : UHS
The strongest argument for UHS centers on P/E Ratio, Return on Equity, Price/Book. PEG of 1.29 suggests the stock is reasonably priced for its growth.
Bear Case : TOI
The primary concerns for TOI are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : UHS
No major red flags identified for UHS, but monitor valuation.
Key Dynamics to Monitor
TOI profiles as a growth stock while UHS is a value play — different risk/reward profiles.
UHS carries more volatility with a beta of 1.26 — expect wider price swings.
TOI is growing revenue faster at 21.5% — sustainability is the question.
UHS generates stronger free cash flow (293M), providing more financial flexibility.
Bottom Line
UHS scores higher overall (76/100 vs 42/100). Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Oncology Institute Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
Oncology Institute Inc (ticker: TOI) is a leading healthcare organization committed to revolutionizing cancer care through its expansive network of specialized clinics and advanced treatment options. Focused on improving patient outcomes, the company utilizes cutting-edge technologies and tailored treatment strategies, while actively engaging in clinical trials and partnerships with esteemed research institutions. As the demand for innovative cancer therapies accelerates, TOI is well-positioned to capitalize on its extensive pipeline and deep oncology expertise, solidifying its role as a vital participant in the dynamic healthcare landscape.
Visit Website →Universal Health Services Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
UnitedHealth Group Incorporated is an American for-profit multinational managed healthcare and insurance company based in Minnetonka, Minnesota. It offers health care products and insurance services.
Visit Website →Compare with Other MEDICAL CARE FACILITIES Stocks
Want to dig deeper into these stocks?